INTERNSHIP DETAILS

Trainee-Streamlining non-clinical requirements for severe debilitating and life-threatening diseases

CompanyEMA
LocationAmsterdam
Work ModeOn Site
PostedApril 10, 2026
Internship Information
Core Responsibilities
The trainee will evaluate the non-clinical development needs for severely debilitating and life-threatening diseases by collecting data from applications and reviewing guidelines to streamline programs. This involves presenting research findings and delivering a report analyzing regulatory trends to inform a reflection paper drafting group.
Internship Type
full time
Company Size
1687
Visa Sponsorship
No
Language
English
Working Hours
40 hours
Apply Now →

You'll be redirected to
the company's application page

About The Company
The European Medicines Agency (EMA) is a decentralised body of the European Union with headquarters in Amsterdam. Its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use.
About the Role

Selection procedure reference: EMA/TR/11363 

Deadline for applications: 06 May 2026 23:59 CET 

 

The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU), located in Amsterdam. It began operating in 1995. It is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.

 

This traineeship opportunity is now open for applications until 06 May 2026 23:59 CET, with an intake on 1 October 2026.

About the traineeship programme

The Agency is looking for motivated, qualified recent graduates or students on an Erasmus+ or other programme or PhD students or Master's students (who posses a previous degree), who are interested in gaining experience and contribute to the Agency’s work for every patient in Europe. The purpose of a traineeship at the Agency is to perform tasks that are predominantly in the interest of the trainee’s training and principally serve to increase the trainee’s knowledge and to gain relevant experience.

Placement description

We are looking for a trainee in the Translational Sciences Office.

Specific objectives and projects

This traineeship will offer the successful candidate the opportunity to strengthen knowledge and expertise in non-clinical development and the 3Rs (Replacement, Reduction, Refinement) at EMA, and to interact with the Non-Clinical Working Party (NcWP), the 3Rs Working Party and the EU regulatory network.
 
The trainee will evaluate the needs for non-clinical development for severely debilitating and life-threatening diseases (SDLT). This will involve collecting data from marketing authorisation applications and scientific advice procedures to gather necessary information. The succesful candidate will also review recently published guidelines and recommendation papers for opportunities to streamline programs for SDLT.
 
The trainee will present the findings of the research at EMA and deliver a report analysing regulatory trends and precedents emerging from EMA procedures on non-clinical development programmes, with the aim of informing the NcWP drafting group preparing a reflection paper on SDLTs.

Learning outcomes

The trainee is expected to:

  • Gain an in-depth understanding of the European Medicines Agency’s (EMA) approach to assessment of the non-clinical dossier submitted by pharmaceutical companies when they seek marketing authorisation for their medicinal products.
  • Gain an understanding of the EMA's scientific advice procedures and how EMA experts advise applicants on critical aspects of a non-clinical devlopment development program.
  • Become familiar with regulatory requirements, agency processes, and regulatory practices related to medicinal products.

 

Eligibility criteria

To be eligible for consideration for this placement, you are required to:

  1. enjoy full rights as a citizen of a European Union Member State or Iceland, Lichtenstein and Norway;
  2. possess a university degree in Non-Clinical Pharmacology, Toxicology, Pharmacy, Biomedical Sciences, or any other Life Sciences (minimum of three years or more) that must have been obtained between 6 May 2025 and 6 May 2026 or be a university student on an Erasmus + or a similar programme or a PhD student or a Master's student with a previous fully finished degree in the areas mentioned before.
  3. a thorough knowledge of English (at least level C1) and good knowledge of other official EU language (at least B2) of the Common European Framework for Languages

For criteria 1 and 2, you will be required to provide proof in the application form and at the interview stage. Failing to present these documents may result in the disqualification from the procedure.

Additional skills

In addition to the eligibility criteria, you will have:

  • Analytical skills and communication skills.
  • Good understanding of Non-Clinical Pharmacology and Toxicology.
  • Understanding of, and/or experience in, the 3Rs (Replacement, Reduction, Refinement) is considered beneficial.

Behavioural Competencies

You will demonstrate the following behavioural competencies:

  • Communication skills
  • Interpersonal skills
  • Working with others
  • Adaptability
  • Research and analytical skills
  • Learning and development

Conditions of traineeship

The traineeship is offered for 10 months (1 October 2026 – 31 July 2027) and takes place at the Agency’s premises in Amsterdam with possibility for teleworking up to 40% of working time from The Netherlands and occasional teleworking from outside The Netherlands. Traineeships are offered for either full-time or part-time (80% or 50%) if combined with university studies.

The Agency pays a monthly stipend of €2,049.77 for a full-time traineeship (reduced accordingly for 80% or 50%) and a travel contribution upon joining the Agency.

Each trainee will have a mentor at the Agency who will guide the trainee through the programme.

The conditions of employment are stated in the Executive Decision on rules governing the traineeship programme at the EMA available here.

Expected selection timelines

Deadline for applications 06 May 2026 23:59 CET 
Assessments (remote)From mid-June 2026 to mid-July 2026
Decision and offers By end of July 2026
Placement start 1 October 2026

 

______________________________________________________________________________________________________

Domenico Scarlattilaan 6 - 1083 HS Amsterdam - The Netherlands

Telephone +31 (0)88 781 6000 - Email recruitment@ema.europa.eu

 

© European Medicines Agency, 2024. Reproduction is authorised provided the source is acknowledged.

Key Skills
Analytical SkillsCommunication SkillsNon-Clinical PharmacologyToxicology3Rs (Replacement, Reduction, Refinement)Data CollectionGuideline ReviewRegulatory Trends Analysis
Categories
Science & ResearchHealthcareLegalGovernment & Public Sector
Benefits
Travel Contribution